Wednesday, July 15, 2009

FDA Draft Guidance on Anti-Counterfeiting

“Drug counterfeiting is a serious public health concern,” said Commissioner of Food and Drugs Margaret A. Hamburg, M.D. “We look forward to working with industry to help ensure that consumers are not exposed to products containing unknown, ineffective, or harmful ingredients,” reports this FDA news release, FDA Issues Draft Guidance for Industry on Drug Anticounterfeiting - Focus on physical chemical identifiers.

The U.S. Food and Drug Administration (FDA) today issued a draft guidance on the use of inks, pigments, flavors, and other physical-chemical identifiers (PCIDs) by manufacturers to make drug products more difficult to duplicate by counterfeiters, and to make it easier to identify the genuine version of the drug. This draft guidance is an important step in working with manufacturers to make drug products more difficult to duplicate by counterfeiters: Draft Guidance for Industry: Incorporation of Physical-Chemical Identifiers into Solid Oral Dosage Form Drug Products for Anticounterfeiting (pdf).

Related Posts:
FDA On Drug Counterfeiting
Gambling With Life - Counterfeit Drugs - Like ED Drugs (Viagra)

Return Home:
The Health, Drug, Prescription, and GMP Supersite Gift Store
Return to Mobile Home:

No comments:

From SkillsPlus International Inc.

Custom Search

Even More Resources, Books, & Things (many from

    GMP Training Gifts & Giveaways